Biomarkers sought to predict COPD attacks

Canadian researcher Don Sin of St. Paul's Hospital, Providence Health Care is working to help people like Vivianne Toupin, who has chronic obstructive pulmonary disease (COPD), a disease that damages the airways and air sacs of the lungs, making it hard to breathe. Sin is leading a multimillion-dollar program within the Center of Excellence for Prevention of Organ Failure (PROOF Center) to discover and develop biomarker blood tests to help clinicians diagnose the disease and predict which COPD patients will experience life-threatening lung attacks. The biomarkers will help doctors to guide therapy after diagnosis. More in Hospital News

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.